17,20-lyase deficiency, isolated, 202110 (3)|CYP17A1, CYP17, P450C17|609300|10q24.32
17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)|CYP17A1, CYP17, P450C17|609300|10q24.32
17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3)|HSD17B10, HADH2, ERAB, MRXS10, MRX17, MRX31, DUPXp11.22|300256|Xp11.22
2-methylbutyrylglycinuria, 610006 (3)|ACADSB, SBCAD|600301|10q26.13
3-M syndrome 1, 273750 (3)|CUL7|609577|6p21.1
3-M syndrome 2, 612921 (3)|OBSL1, KIAA0657, 3M2|610991|2q35
3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)|MCCC1, MCCA|609010|3q27.1
3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)|MCCC2, MCCB|609014|5q13.2
3-beta-hydroxysteroid dehydrogenase, type II, deficiency, 201810 (3)|HSD3B2|613890|1p12
3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3)|HADHSC, SCHAD, HHF4|601609|4q25
3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)|HIBCH|610690|2q32.2
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3)|SERAC1, MEGDEL|614725|6q25.3
3-methylglutaconic aciduria, type I, 250950 (3)|AUH|600529|9q22.31
3-methylglutaconic aciduria, type III, 258501 (3)|OPA3, MGA3|606580|19q13.32
3-methylglutaconic aciduria, type V, 610198 (3)|DNAJC19, TIM14|608977|3q26.33
3MC syndrome 1, 257920 (3)|MASP1, CRARF, 3MC1|600521|3q27.3
3MC syndrome 2, 265050 (3)|COLEC11, CLK1, 3MC2|612502|2p25.3
3p- syndrome (4)|DEL3pterp25, C3DELpterp25|613792|3pter-p25
3q21q26 syndrome (1)|EVI1|165215|3q26.2
46XX sex reversal 1, 400045 (3)|SRY, TDF, TDY, SRXX1, SRXY1|480000|Yp11.31
46XX sex reversal 2, 278850 (4)|SRXX2, DUP17q24.3, DEL17q24.3|278850|17q24.3-q25.1
46XX sex reversal 3 (4)|SRXX3|300833|Xq26.3
46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3)|DHH, SRXY7, GDXYM|605423|12q13.12
46XY sex reversal 1, 400044 (3)|SRY, TDF, TDY, SRXX1, SRXY1|480000|Yp11.31
46XY sex reversal 2, dosage-sensitive, 300018 (3)|DAX1, AHC, AHX, NROB1, SRXY2|300473|Xp21.2
46XY sex reversal 3, 612965 (3)|NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8|184757|9q33.3
46XY sex reversal 4 (4)|DEL9p24.3, C9DELp24.3, SRXY4|154230|9p24.3
46XY sex reversal 5, 613080 (3)|CBX2, M33, SRXY5|602770|17q25.3
46XY sex reversal 6, 613762 (3)|MAP3K1, MEKK1, MEKK, SRXY6|600982|5q11.2
46XY sex reversal 7, 233420 (3)|DHH, SRXY7, GDXYM|605423|12q13.12
46XY sex reversal 8, 614279 (3)|AKR1C2, DDH2, DD2, HAKRD, SRXY8|600450|10p15.1
5-fluorouracil toxicity, 274270 (3)|DPYD, DPD|612779|1p21.3
5-oxoprolinase deficiency, 260005 (3)|OPLAH, OPLAHD|614243|8q24.3
6-mercaptopurine sensitivity, 610460 (3)|TPMT|187680|6p22.3
?ACAT2 deficiency, 614055 (1)|ACAT2|100678|6q25.3
?Amelogenesis imperfecta-3, hypoplastic type (2)|AIH3|301201|Xq22-q28
?Anal canal carcinoma (2)|ANC|105580|11q22-qter
?Antiphospholipid syndrome, familial (2)|ATPLS|107320|6p21.3
?Arrhythmogenic right ventricular dysplasia 5, 604400 (1)|LAMR1, LAMBR|150370|3p22.1
?Breast cancer, type 3 (2)|BRCA3, BRCAX|605365|13q21
?Cardiomyopathy, dilated, 115200 (3)|MYBPC3, CMH4|600958|11p11.2
?Carnitine acetyltransferase deficiency (1)|CRAT, CAT1|600184|9q34.11
?Cataract, anterior polar-1 (2)|CTAA1|115650|14q24-qter
?Cataract, congenital (2)|SORD, SORD1|182500|15q21.1
?Coffin-Siris syndrome (2)|CSS|135900|7q32-q34
?Colon cancer (1)|SLC26A3, DRA, CLD|126650|7q31.1
?Craniofacioskeletal syndrome (2)|CFSS|300712|Xq26-q27
?Cutis laxa, marfanoid neonatal type, 614100 (1)|LAMB1|150240|7q31.1
?DECR deficiency (2)|DECR1|222745|8q21.3
?Deafness, nonsyndromic (3)|KIAA1199|608366|15q25.1
?Diabetes mellitus, insulin-dependent, neonatal (2)|PBCA|600089|6p21.3
?Dicarboxylicaminoaciduria, 222730 (1)|SLC1A1, EAAC1|133550|9p24.2
?EEC syndrome-1 (2)|EEC1|129900|7q11.2-q21.3
?Fetal hydantoin syndrome (1)|EPHX1|132810|1q42.12
?Globozoospermia, 102530 (1)|GOPC, PIST, FIG, CAL|606845|6q22.1
?Glycoprotein Ia deficiency, 614200 (1)|ITGA2, CD49B, BR, BDPLT9|192974|5q11.2
?Hairy ears, Y-linked (2)|HEY|425500|Yq
?Hepatocellular carcinoma (1)|LCO|165320|2q14-q21
?Heterotaxy, visceral, 3, autosomal (2)|HTX3|606325|6q21
?Hyperimmunoglobulin G1 syndrome (2)|IGHR|144120|14q32.33
?Hyperleucinemia-isoleucinemia or hypervalinemia (1)|BCAT1, BCT1|113520|12p12.1
?Hypertension, essential, 145500 (1)|PNMT, PENT|171190|17q12
?Hypertension, salt-resistant (1)|NPR3, ANPRC|108962|5p13.3
?Hypertrichosis universalis congenita, Ambras type (2)|ITC1|145701|8q22
?Hypervalinemia or hyperleucine-isoleucinemia (1)|BCAT2, BCT2|113530|19q13.33
?Isolated growth hormone deficiency due to defect in GHRF (1)|GHRH, GHRF|139190|20q11.23
?Keratoderma, palmoplantar, punctate type 3 (2)|PPKP3|101850|2p25-p12
?Klippel-Feil syndrome 2, autosomal recessive (2)|KFS2, KFM|214300|5q11.2
?Laryngeal adductor paralysis (2)|LAP|150270|6p21.3-p21.2
?Lysosomal acid phosphatase deficiency, 200950 (1)|ACP2|171650|11p11.2
?Male infertility (1)|UBE2B, RAD6B|179095|5q31.1
?Male infertility due to acrosin deficiency (2)|ACR|102480|22q13.33
?Male pseudohermaphroditism due to defective LH (1)|LHB|152780|19q13.33
?Melkersson-Rosenthal syndrome (2)|MROS|155900|9p11
?Mental retardation, X-linked, syndromic 12 (2)|MRXS12|309545|Xp11
?Mental retardation, nonsyndromic, X-linked (2)|KIAA2022|300524|Xq13.3
?Microphthalmia, syndromic 4 (2)|MCOPS4, ANOP1|301590|Xq27-q28
?Moebius syndrome (2)|MBS, MBS1|157900|13q12.2-q13
?N syndrome, 310465 (1)|POLA1|312040|Xp22.1-p21.3
?Neuroblastoma (1)|TP73|601990|1p36.32
?Neutrophil chemotactic repsonse, abnormal (2)|NM, NCR|162820|7q22-qter
?Osteoporosis, involutional, 166710 (1)|VDR|601769|12q13.11
?Paget disease of bone (2)|PDB|167250|6p21.3
?Pancreatic endocrine tumors (1)|ST11, PETS1|602011|3p25
?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, 261680 (1)|PCK1|614168|20q13.31
?Preauricular fistulae, congenital (2)|PAFC|128700|8q11.1-q13.3
?Prinzmetal angina (1)|KCNJ8|600935|12p12.1
?Progesterone resistance, 264080 (2)|PGR|607311|11q22.1
?Ptosis, congenital, 178300 (2)|ZFHX4, ZFH4|606940|8q21.11
?Ragweed sensitivity (2)|RWS|179450|6p21.3
?Retinal cone dystrophy-1 (2)|RCD1|180020|6q25-q26
?Retinitis pigmentosa, X-linked recessive, 6 (2)|RP6|312612|Xp21.3-p21.2
?Roifman-Chitayat syndrome (2)|RCHTS|613328|15q11-q21.1
?Sertoli-cell-only syndrome (1)|DAZ|400003|Yq11.223
?Spastic paraplegia 41, autosomal dominant (2)|SPG41|613364|11p14.1-p11.2
?Spinocerebellar ataxia 30 (2)|SCA30|613371|4q34.3-q35.1
?Stomatocytosis I, 185000 (1)|EPB72|133090|9q33.2
?Systemic lupus erythematosus, susceptibility to or protection against}, 152700 (2)|C4A, C4S, C4AD|120810|6p21.33
?Testicular microlithiasis, 610441 (3)|SLC34A2|604217|4p15.2
?Tetramelic mirror-image polydactyly (2)|TMIP|135750|14q13
?Thrombocytopenia, Paris-Trousseau type (4)|TCPT|188025|11q23
?Thrombophilia due to decreased release of tissue plasminogen (1)|THPH9|612348|8p12
?Thromboxane synthase deficiency, 614158 (1)|TBXAS1, GHOSAL, CYP5, BDPLT14|274180|7q34
?Tibial hemimelia (2)|THM|275220|8q24.1
?Xeroderma pigmentosum (1)|PARP1, ADPRT, PPOL, PARP|173870|1q42.12
?Zimmermann-Laband syndrome (2)|ZLS|135500|3p14.3
ABCD syndrome, 600501 (3)|EDNRB, HSCR2, ABCDS, WS4A|131244|13q22.3
ACAD9 deficiency, 611126 (3)|ACAD9|611103|3q21.3
ACTH-independent macronodular adrenal hyperplasia, 219080 (3)|GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C|139320|20q13.32
ADULT syndrome, 103285 (3)|TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8|603273|3q28
AGAT deficiency, 612718 (3)|GATM, AGAT|602360|15q21.1
AICA-ribosiduria due to ATIC deficiency, 608688 (3)|ATIC, PURH, AICAR|601731|2q35
Aarskog-Scott syndrome, 305400 (3)|FGD1, FGDY, AAS, MRXS16|300546|Xp11.22
Abdominal obesity-metabolic syndrome (2)|AOMS1, SYNX|605552|3q27
Abdominal obesity-metabolic syndrome (2)|AOMS2|605572|17p12
Abetalipoproteinemia, 200100 (3)|MTP|157147|4q23
Acampomelic campomelic dysplasia, 114290 (3)|SOX9, CMD1, SRA1|608160|17q24.3
Acatalasemia, 614097 (3)|CAT|115500|11p13
Acetabular dysplasia (2)|ACTD|142700|13q22
Acetyl-CoA carboxylase deficiency, 613933 (1)|ACACA, ACAC, ACC1, ACACAD|200350|17q12
Achalasia-addisonianism-alacrimia syndrome, 231550 (3)|AAAS, AAA|605378|12q13.13
Acheiropody, 200500 (3)|LMBR1, ACHP, C7orf2, PPD2|605522|7q36.3
Achondrogenesis Ib, 600972 (3)|SLC26A2, DTD, DTDST, D5S1708, EDM4|606718|5q32
Achondrogenesis, type IA, 200600 (3)|TRIP11, TRIP230, CEV14, ACG1A|604505|14q32.12
Achondrogenesis, type II or hypochondrogenesis, 200610 (3)|COL2A1|120140|12q13.11
Achondroplasia, 100800 (3)|FGFR3, ACH|134934|4p16.3
Achromatopsia-2, 216900 (3)|CNGA3, CNG3, ACHM2|600053|2q11.2
Achromatopsia-3, 262300 (3)|CNGB3, ACHM3, ACHM1|605080|8q21.3
Achromatopsia-4, 613856 (3)|GNAT2, ACHM4|139340|1p13.3
Acid-labile subunit, deficiency of (3)|IGFALS, ALS|601489|16p13.3
Acne inversa, familial, 1, 142690 (3)|NCSTN|605254|1q23.2
Acne inversa, familial, 2, 613736 (3)|PSENEN, PEN2|607632|19q13.12
Acne inversa, familial, 3, 613737 (3)|PSEN1, AD3|104311|14q24.2
Acrocallosal syndrome, 200990 (3)|KIF7, HLS2, ACLS, JBTS12|611254|15q26.1
Acrocapitofemoral dysplasia, 607778 (3)|IHH, BDA1|600726|2q35
Acrodermatitis enteropathica, 201100 (3)|SLC39A4, ZIP4|607059|8q24.3
Acrodysostosis 1, with or without hormone resistance, 101800 (3)|PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1|188830|17q24.2
Acrodysostosis 2, with or without hormone resistance, 614613 (3)|PDE4D, DPDE3, STRK1, ACRDYS2|600129|5q11.2-q12.1
Acrofacial dysostosis 1, Nager type, 154400 (3)|SF3B4, SF3B49, SAP49, AFD1|605593|1q21.2
Acrokeratosis verruciformis, 101900 (3)|ATP2A2, ATP2B, DAR|108740|12q24.11
Acromegaloid features, overgrowth, cleft palate, and hernia (2)|AOCH|606049|Chr.11
Acromegaly, 102200 (3)|GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C|139320|20q13.32
Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)|GDF5, CDMP1, SYNS2, OS5|601146|20q11.22
Acromesomelic dysplasia, Maroteaux type, 602875 (3)|NPR2, ANPRB, AMDM|108961|9p13.3
Acromicric dysplasia, 102370 (3)|FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1|134797|15q21.1
Acropectoral syndrome (2)|ACRPS|605967|7q36
Acropectorovertebral dysplasia (2)|ACRPV|102510|2q36
Acute insulin response (2)|AIR|601676|1p31
Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)|ACADM, MCAD|607008|1p31.1
Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)|ACADS, SCAD|606885|12q24.31
Adams-Oliver syndrome 1, 100300 (3)|ARHGAP31, CDGAP, KIAA1204, AOS1|610911|3q13.33
Adams-Oliver syndrome 2, 614219 (3)|DOCK6, KIAA1395, AOS2|614194|19p13.2
Adams-Oliver syndrome 3, 614814 (3)|RBPJ, RBPSUH, IGKJRB1, AOS3|147183|4p15.2
Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)|EGFR|131550|7p11.2
Adenocarcinoma of lung, somatic, 211980 (3)|BRAF, NS7|164757|7q34
Adenocarcinoma of lung, somatic, 211980 (3)|ERBB2, NGL, NEU, HER2|164870|17q12
Adenocarcinoma of lung, somatic, 211980 (3)|PRKN, PARK2, PDJ, LPRS2|602544|6q26
Adenocarcinoma, colonic, somatic (3)|RAD54L, HR54, HRAD54|603615|1p34.1
Adenocarcinoma, ovarian, somatic, 167000 (3)|PRKN, PARK2, PDJ, LPRS2|602544|6q26
Adenoma, periampullary, somatic (3)|APC, GS, FPC, BTPS2|611731|5q22.2
Adenomas, multiple colorectal, 608456 (3)|MUTYH, MYH|604933|1p34.1
Adenomas, salivary gland pleomorphic, 181030 (3)|PLAG1, SGPA, PSA|603026|8q12.1
Adenomatous polyposis coli, 175100 (3)|APC, GS, FPC, BTPS2|611731|5q22.2
Adenosine deaminase deficiency, partial, 102700 (3)|ADA|608958|20q13.12
Adenosine triphosphate, elevated, of erythrocytes, 102900 (3)|PKLR, PK1|609712|1q22
Adenylosuccinase deficiency, 103050 (3)|ADSL|608222|22q13.1
Adermatoglyphia, 136000 (3)|SMARCAD1, KIAA1122, ETL1, HEL1, ADERM|612761|4q22.3
Adhalinopathy, primary (1)|SGCA, ADL, DAG2, LGMD2D, DMDA2|600119|17q21.33
Adiponectin deficiency, 612556 (3)|ADIPOQ, APM1, GBP28, ADIPQTL1|605441|3q27.3
Adrenal adenoma, somatic (3)|MEN1|613733|11q13.1
Adrenal cortical carcinoma, 202300 (3)|TP53, P53, LFS1 , BCC7|191170|17p13.1
Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3)|CYP11B1, P450C11, FHI|610613|8q24.3
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3)|CYP21A2, CYP21, CA21H|613815|6p21.33
Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism, 300200 (3)|DAX1, AHC, AHX, NROB1, SRXY2|300473|Xp21.2
Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)|CYP11A, P450SCC|118485|15q24.1
Adrenocortical insufficiency (3)|NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8|184757|9q33.3
Adrenocortical tumor, somatic, (3)|PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1|188830|17q24.2
Adrenocorticotropic hormone deficiency, 201400 (3)|TBX19|604614|1q24.2
Adrenoleukodystrophy, 300100 (3)|ABCD1, ALD, AMN|300371|Xq28
Adrenoleukodystrophy, neonatal, 202370 (3)|PEX1, ZWS1|602136|7q21.2
Adrenoleukodystrophy, neonatal, 202370 (3)|PEX10, NALD|602859|1p36.32
Adrenoleukodystrophy, neonatal, 202370 (3)|PEX13, ZWS, NALD|601789|2p16.1
Adrenoleukodystrophy, neonatal, 202370 (3)|PEX26|608666|22q11.21
Adrenoleukodystrophy, neonatal, 202370 (3)|PEX5, PXR1, PTS1R|600414|12p13.31
Adrenomyeloneuropathy, 300100 (3)|ABCD1, ALD, AMN|300371|Xq28
Adult i phenotype with congenital cataract, 110800 (3)|GCNT2|600429|6p24.3-p24.2
Adult i phenotype without cataract, 110800 (3)|GCNT2|600429|6p24.3-p24.2
Advanced sleep phase syndrome, familial, 604348 (3)|PER2, FASPS, KIAA0347|603426|2q37.3
Afibrinogenemia, congenital, 202400 (3)|FGA|134820|4q31.3
Afibrinogenemia, congenital, 202400 (3)|FGB|134830|4q31.3
Agammaglobulinemia 1, 601495 (3)|IGHM, MU, AGM1|147020|14q32.33
Agammaglobulinemia 2, 613500 (3)|IGLL1, IGO, IGL5, VPREB2, AGM2|146770|22q11.23
Agammaglobulinemia 3, 613501 (3)|CD79A, IGA|112205|19q13.2
Agammaglobulinemia 4, 613502 (3)|BLNK, SLP65, AGM4|604515|10q24.1
Agammaglobulinemia 5, 613506 (3)|LRRC8A, KIAA1437, AGM5|608360|9q34.11
Agammaglobulinemia 6, 612692 (3)|CD79B, IGB, B29, AGM6|147245|17q23.3
Agammaglobulinemia and isolated hormone deficiency, 307200 (3)|BTK, AGMX1, IMD1, XLA, AT|300300|Xq22.1
Agammaglobulinemia, X-linked 1, 300755 (3)|BTK, AGMX1, IMD1, XLA, AT|300300|Xq22.1
Agammaglobulinemia, X-linked 2 (2)|AGMX2, XLA2, IMD6|300310|Xp22
Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)|SLC12A6, KCC3A, KCC3B, KCC3, ACCPN|604878|15q14
Agnathia-otocephaly complex, 202650 (3)|PRRX1, PMX1, PHOX1, AGOTC|167420|1q24.2
Aicardi syndrome (2)|AIC|304050|Xp22
Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3)|TREX1, AGS1, CRV, HERNS|606609|3p21.31
Aicardi-Goutieres syndrome 2, 610181 (3)|RNASEH2B, DLEU8, FLJ11712, AGS2|610326|13q14.3
Aicardi-Goutieres syndrome 3, 610329 (3)|RNASEH2C, AYP1, FLJ20974, AGS3|610330|11q13.1
Aicardi-Goutieres syndrome 4, 610333 (3)|RNASEH2A, RNHIA, AGS4|606034|19p13.2
Aicardi-Goutieres syndrome 5, 612952 (3)|SAMHD1, AGS5, DCIP, CHBL2|606754|20q11.23
Alagille syndrome 2, 610205 (3)|NOTCH2, AGS2, HJCYS|600275|1p12-p11
Alagille syndrome, 118450 (3)|JAG1, AGS, AHD|601920|20p12.2
Aland Island eye disease, 300600 (3)|CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2|300110|Xp11.23
Albinism, brown oculocutaneous, 203200 (3)|OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1|611409|15q12-q13
Albinism, oculocutaneous, type IA, 203100 (3)|TYR, SHEP3, CMM8|606933|11q14.3
Albinism, oculocutaneous, type IB, 606952 (3)|TYR, SHEP3, CMM8|606933|11q14.3
Albinism, oculocutaneous, type II, 203200 (3)|OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1|611409|15q12-q13
Albinism, oculocutaneous, type III, 203290 (3)|TYRP1, CAS2, GP75, SHEP11|115501|9p23
Albinism-deafness syndrome (2)|ADFN, ALDS|300700|Xq24-q26
Alcohol sensitivity, acute, 610251 (3)|ALDH2|100650|12q24.12
Aldosterone to renin ratio raised (3)|CYP11B2|124080|8q24.3
Aldosteronism, glucocorticoid-remediable, 103900 (3)|CYP11B1, P450C11, FHI|610613|8q24.3
Alexander disease, 203450 (3)|GFAP|137780|17q21.31
Alkaptonuria, 203500 (3)|HGD, AKU|607474|3q13.33
Allan-Herndon-Dudley syndrome, 300523 (3)|SLC16A2, DXS128, XPCT|300095|Xq13.2
Alopecia areata 1 (2)|AA1|104000|18p11.3-p11.2
Alopecia areata 2 (2)|AA2|610753|16q11-q22
Alopecia universalis, 203655 (3)|HR, AU, MUHH1|602302|8p21.3
Alopecia with mental retardation syndrome 1 (2)|APMR1|203650|3q26.3-q27.3
Alopecia with mental retardation syndrome 2 (2)|APMR2|610422|3q26.2-q26.31
Alopecia, androgenetic, 1 (2)|AFA1, MPB|109200|3q26
Alopecia, androgenetic, 2 (2)|AGA2|300710|Xq11-q12
Alopecia, androgenetic, 3 (2)|AGA3|612421|20p11.22
Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)|RBM28|612074|7q32.1
Alopecia-mental retardation syndrome 3 (2)|APMR3|613930|18q11.2-q12.2
Alpha-1-antichymotrypsin deficiency (3)|SERPINA3, AACT, ACT|107280|14q32.13
Alpha-2-macroglobulin deficiency, 614036 (1)|A2M , A2MD|103950|12p13.31
Alpha-2-plasmin inhibitor deficiency, 262850 (3)|PLI, SERPINF2|613168|17p13.3
Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1)|OGDH|613022|7p13
Alpha-methylacetoacetic aciduria, 203750 (3)|ACAT1|607809|11q22.3
Alpha-methylacyl-CoA racemase deficiency, 614307 (3)|AMACR, CBAS4, AMACRD|604489|5p13.2
Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)|ATRX, XH2, XNP, SHS, SFM1, MRXHF1|300032|Xq21.1
Alpha-thalassemia/mental retardation syndrome, 301040 (3)|ATRX, XH2, XNP, SHS, SFM1, MRXHF1|300032|Xq21.1
Alpha-thalassemia/mental retardation syndrome, type 1 (4)|HBHR, ATR1|141750|16pter-p13.3
Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3)|RAG1|179615|11p12
Alport syndrome, 301050 (3)|COL4A5, ATS, ASLN|303630|Xq22.3
Alport syndrome, autosomal dominant, 104200 (3)|COL4A3|120070|2q36.3
Alport syndrome, autosomal recessive, 203780 (3)|COL4A3|120070|2q36.3
Alport syndrome, autosomal recessive, 203780 (3)|COL4A4|120131|2q36.3
Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (4)|AMMEC, DELXq22.3, CXDELq22.3|300194|Xq22.3
Alstrom syndrome, 203800 (3)|ALMS1, ALSS, KIAA0328|606844|2p13.1
Alternating hemiplegia of childhood 2, 614820 (3)|ATP1A3, DYT12, RDP, AHC2|182350|19q13.2
Alternating hemiplegia of childhood, 104290 (3)|ATP1A2, FHM2, MHP2|182340|1q23.2
Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)|FOXF1, FKHL5, ACDMPV|601089|16q24.1
Alveolar soft-part sarcoma, 606243 (3)|ASPSCR1, RCC17, ASPL, ASPS|606236|17q25.3
Alzheimer disease 1, familial, 104300 (3)|APP, AAA, CVAP, AD1|104760|21q21.3
Alzheimer disease 6, 104300 (2)|AD6|605526|10q24
Alzheimer disease 8, 104300 (2)|AD8|607116|20p
Alzheimer disease, type 3, 607822 (3)|PSEN1, AD3|104311|14q24.2
Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3)|PSEN1, AD3|104311|14q24.2
Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3)|PSEN1, AD3|104311|14q24.2
Alzheimer disease-10, 104300 (2)|AD10|609636|7q36
Alzheimer disease-11 (2)|AD11|609790|9p22.1
Alzheimer disease-2, 104310 (3)|APOE, AD2, LPG, LDLCQ5|107741|19q13.32
Alzheimer disease-4, 606889 (3)|PSEN2, AD4, STM2, CMD1V|600759|1q42.13
Alzheimer disease-5, 104300 (2)|AD5|602096|12p11.23-q13.12
Alzheimer disease-7 (2)|AD7|606187|10p13
Amelogenesis imperfecta and gingival fibromatosis syndrome, 614253 (3)|FAM20A, AIGFS|611062|17q24.2
Amelogenesis imperfecta, hypomaturation type, IIA3, 613211 (3)|WDR72, AI2A3|613214|15q21.3
Amelogenesis imperfecta, hypomaturation-hypoplastic type, with taurodontism, 104510 (3)|DLX3, TDO, AI4|600525|17q21.33
Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E, 301200 (3)|AMELX, AMG, AIH1, AMGX, AI1E|300391|Xp22.2
Amelogenesis imperfecta, type 3, 130900 (3)|FAM83H, AI3|611927|8q24.3
Amelogenesis imperfecta, type IB, 104500 (3)|ENAM, AIH2, AI1C|606585|4q13.3
Amelogenesis imperfecta, type IC, 204650 (3)|ENAM, AIH2, AI1C|606585|4q13.3
Amelogenesis imperfecta, type IIA1, 204700 (3)|KLK4, EMSP1, PRSS17, AI2A1|603767|19q13.41
Amelogenesis imperfecta, type IIA2, 612529 (3)|MMP20, AI2A2|604629|11q22.2
Aminoacylase 1 deficiency, 609924 (3)|ACY1, ACY1D|104620|3p21.2
Amish infantile epilepsy syndrome, 609056 (3)|SIAT9, ST3GALV|604402|2p11.2
Amyloidosis, 3 or more types, 105200 (3)|APOA1|107680|11q23.3
Amyloidosis, Finnish type, 105120 (3)|GSN|137350|9q33.2
Amyloidosis, hereditary renal, 105200 (3)|FGA|134820|4q31.3
Amyloidosis, hereditary, transthyretin-related, 105210 (3)|TTR, PALB|176300|18q12.1
Amyloidosis, primary localized cutaneous, 1, 105250 (3)|OSMR, OSMRB, PLCA1|601743|5p13.1
Amyloidosis, primary localized cutaneous, 2, 613955 (3)|IL31RA, GLMR, GPL, PLCA2|609510|5q11.2
Amyloidosis, renal, 105200 (3)|LYZ|153450|12q15
Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3)|TARDBP, TDP43, ALS10|605078|1p36.22
Amyotrophic lateral sclerosis 11, 612577 (3)|FIG4, KIAA0274, SAC3, ALS11|609390|6q21
Amyotrophic lateral sclerosis 12, 613435 (3)|OPTN, GLC1E, FIP2, HYPL, NRP, ALS12|602432|10p13
Amyotrophic lateral sclerosis 14 with or without frontotemporal dementia, 613954 (3)|VCP, IBMPFD, ALS14|601023|9p13.3
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)|UBQLN2, PLIC2, CHAP1, ALS15|300264|Xp11.21
Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)|SIGMAR1, SRBP, ALS16|601978|9p13.3
Amyotrophic lateral sclerosis 17, 614696 (3)|CHMP2B, DMT1, VPS2B, ALS17|609512|3p11.2
Amyotrophic lateral sclerosis 18, 614808 (3)|PFN1, ALS18|176610|17p13.2
Amyotrophic lateral sclerosis 3 (2)|ALS3|606640|18q21
Amyotrophic lateral sclerosis 4, juvenile, 602433 (3)|SETX, SCAR1, AOA2, ALS4|608465|9q34.13
Amyotrophic lateral sclerosis 6, autosomal recessive, with or without frontotemporal dementia, 608030 (3)|FUS, TLS, ALS6, ETM4|137070|16p11.2
Amyotrophic lateral sclerosis 7 (2)|ALS7|608031|20p13
Amyotrophic lateral sclerosis 8, 608627 (3)|VAPB, VAPC, ALS8|605704|20q13.32
Amyotrophic lateral sclerosis 9, 611895 (3)|ANG, RNASE5, ALS9|105850|14q11.2
Amyotrophic lateral sclerosis with frontotemporal dementia, 105550 (3)|C9orf72, FTDALS, ALSFTD|614260|9p21.2
Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)|SOD1, ALS1|147450|21q22.11
Amyotrophic lateral sclerosis, juvenile, 205100 (3)|ALS2, ALSJ, PLSJ, IAHSP|606352|2q33.1
Amyotrophic lateral sclerosis-5, juvenile recessive (2)|ALS5|602099|15q15.1-q21.1
Amyotrophic lateral sclerosis-Parkinsonism/dementia complex 2 (3)|DJ1, PARK7|602533|1p36.23
Amyotrophy, hereditary neuralgic, 162100 (3)|SEPT9, MSF, MSF1, NAPB|604061|17q25.2-q25.3
Analbuminemia (3)|ALB|103600|4q13.3
Anauxetic dysplasia, 607095 (3)|RMRP, RMRPR, CHH|157660|9p13.3
Andersen syndrome, 170390 (3)|KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9|600681|17q24.3
Androgen insensitivity, 300068 (3)|AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1|313700|Xq12
Androgen insensitivity, partial, with or without breast cancer, 312300 (3)|AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1|313700|Xq12
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)|GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP|305371|Xp11.23
Anemia, congenital dyserythropoietic, type I, 224120 (3)|CDAN1, CDA1|607465|15q15.2
Anemia, dyserythropoietic congenital, type II, 224100 (3)|SEC23B, CDAN2, HEMPAS|610512|20p11.23
Anemia, dyserythropoietic congenital, type IV, 613673 (3)|KLF1, EKLF, INLU, HBFQTL6|600599|19p13.2
Anemia, hemolytic, Rh-null, regulator type, 268150 (3)|RHAG, RH50A|180297|6p12.3
Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)|NT5C3, UMPH1, PSN1|606224|7p14.3
Anemia, hypochromic microcytic, 206100 (3)|NRAMP2|600523|12q13.12
Anemia, neonatal hemolytic, fatal and near-fatal (3)|SPTB, SPH2, EL3, HS2|182870|14q23.3
Anemia, sideroblastic, X-linked, 300751 (3)|ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1|301300|Xp11.21
Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive, 205950 (3)|GLRX5, C14orf87, PRO1238, FLB4739|609588|14q32.13
Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive, 205950 (3)|SLC25A38|610819|3p22.1
Anemia, sideroblastic, with ataxia, 301310 (3)|ABCB7, ABC7, ASAT|300135|Xq13.3
Aneurysm, intracranial berry, 1 (2)|ANIB1|105800|7q11.2
Aneurysm, intracranial berry, 11 (2)|ANIB11|614252|8p22
Aneurysm, intracranial berry, 2 (2)|ANIB2|608542|19q13
Aneurysm, intracranial berry, 3 (2)|ANIB3|609122|1p36.13-p34.3
Aneurysm, intracranial berry, 4 (2)|ANIB4|610213|5p15.2-p14.3
Aneurysm, intracranial berry, 5 (2)|ANIB5|300870|Xp22
Aneurysm, intracranial berry, 5 (2)|ANIB5|610402|2p15-q14
Aneurysm, intracranial berry, 7 (2)|ANIB7|612161|11q24-q25
Aneurysm, intracranial berry, 8 (2)|ANIB8|612162|14q23
Aneurysmal bone cysts (2)|ANBC|606179|16q22
Angelman syndrome, 105830 (3)|MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16|300005|Xq28
Angelman syndrome, 105830 (3)|UBE3A, ANCR|601623|15q11.2
Angelman syndrome-like, 105830 (3)|CDKL5, STK9, ISSX, EIEE2|300203|Xp22.13
Angio serpiginosum (2)|AGSPX|300652|Xp11.3-q12
Angioedema, hereditary, type III, 610618 (3)|F12, HAF, HAE3|610619|5q35.3
Angioedema, hereditary, types I and II, 106100 (3)|C1NH, HAE1, HAE2, SERPING1|606860|11q12.1
Angiofibroma, somatic (3)|MEN1|613733|11q13.1
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle, 611773 (3)|COL4A1, POREN1, HANAC|120130|13q34
Aniridia, 106210 (3)|PAX6, AN2, MGDA|607108|11p13
Anisomastia (2)|ANMA|605746|16q13-q21
Anonychia congenita, 206800 (3)|RSPO4, CRISTIN4|610573|20p13
Anosmia, isolated congenital (2)|ANIC|107200|18p11.23-q12.2
Anterior segment anomalies with or without cataract, 113650 (3)|EYA1, BOR, BOS1|601653|8q13.3
Anterior segment mesenchymal dysgenesis, 107250 (3)|FOXE3, FKHL12, ASMD|601094|1p33
Anterior segment mesenchymal dysgenesis, 107250 (3)|PITX3, CTPP4|602669|10q24.32
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3)|POR|124015|7q11.23
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3)|FGFR2, BEK, CFD1, JWS, TK14, BBDS|176943|10q26.13
Aortic aneurysm, ascending, and dissection (3)|FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1|134797|15q21.1
Aortic aneurysm, familial abdominal 1 (2)|AAA1, AAA|100070|19q13
Aortic aneurysm, familial abdominal 2 (2)|AAA2|609782|4q31
Aortic aneurysm, familial abdominal, 4 (2)|AAA4|614375|12q13.3
Aortic aneurysm, familial thoracic 1 (2)|AAT1, FAA1|607086|11q23.3-q24
Aortic aneurysm, familial thoracic 2 (2)|AAT2, FAA2|607087|5q13-q14
Aortic aneurysm, familial thoracic 4, 132900 (3)|MYH11, AAT4, FAA4|160745|16p13.11
Aortic aneurysm, familial thoracic 6, 611788 (3)|ACTA2, ACTSA, AAT6, MYMY5|102620|10q23.31
Aortic aneurysm, familial thoracic 7, 613780 (3)|MYLK, MLCK, AAT7|600922|3q21.1
Aortic valve disease 2, 614823 (3)|MADH6, SMAD6, AOVD2|602931|15q22.31
Aortic valve disease, 109730 (3)|NOTCH1, TAN1|190198|9q34.3
Apert syndrome, 101200 (3)|FGFR2, BEK, CFD1, JWS, TK14, BBDS|176943|10q26.13
Aphakia, congenital primary, 610256 (3)|FOXE3, FKHL12, ASMD|601094|1p33
Aphasia, primary progressive, 607485 (3)|GRN, CLN11|138945|17q21.31
Aplasia of lacrimal and salivary glands, 180920 (3)|FGF10|602115|5p12
Apnea, postanesthetic (3)|BCHE, CHE1|177400|3q26.1
ApoA-I and apoC-III deficiency, combined (3)|APOA1|107680|11q23.3
Apolipoprotein A-II deficiency (3)|APOA2|107670|1q23.3
Apparent mineralocorticoid excess, 218030 (3)|HSD11B2, HSD11K, AME|614232|16q22.1
Argininemia, 207800 (3)|ARG1|608313|6q23.2
Argininosuccinic aciduria, 207900 (3)|ASL|608310|7q11.21
Aromatase deficiency, 613546 (3)|CYP19A1, CYP19, ARO|107910|15q21.2
Aromatase excess syndrome, 139300 (3)|CYP19A1, CYP19, ARO|107910|15q21.2
Aromatic L-amino acid decarboxylase deficiency, 608643 (3)|DDC|107930|7p12.1
Arrhythmogenic right ventricular dysplasia 1, 107970 (3)|TGFB3|190230|14q24.3
Arrhythmogenic right ventricular dysplasia 10, 610193 (3)|DSG2, ARVD10, ARVC10, CMD1BB|125671|18q12.1
Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3)|DSC2, DSC3, ARVD11|125645|18q12.1
Arrhythmogenic right ventricular dysplasia 11, 610476 (3)|DSC2, DSC3, ARVD11|125645|18q12.1
Arrhythmogenic right ventricular dysplasia 12, 611528 (3)|JUP, DP3, PDGB, ARVD12|173325|17q21.2
Arrhythmogenic right ventricular dysplasia 2, 600996 (3)|RYR2, VTSIP, ARVD2, ARVC2|180902|1q43
Arrhythmogenic right ventricular dysplasia 3 (2)|ARVD3|602086|14q12-q22
Arrhythmogenic right ventricular dysplasia 4 (2)|ARVD4|602087|2q32.1-q32.3
Arrhythmogenic right ventricular dysplasia 5, 604400 (3)|TMEM43, ARVD5, ARVC5|612048|3p25.1
Arrhythmogenic right ventricular dysplasia 6 (2)|ARVD6|604401|10p14-p12
Arrhythmogenic right ventricular dysplasia 7 (2)|ARVD7, ARVC7|609160|10q22.3
Arrhythmogenic right ventricular dysplasia 8, 607450 (3)|DSP, KPPS2, PPKS2|125647|6p24.3
Arrhythmogenic right ventricular dysplasia 9, 609040 (3)|PKP2, ARVD9|602861|12p11.21
Arterial calcification, generalized, of infancy, 1, 208000 (3)|ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2|173335|6q23.2
Arterial calcification, generalized, of infancy, 2, 614473 (3)|ABCC6, ARA, ABC34, MLP1, PXE, GACI2|603234|16p13.11
Arterial tortuosity syndrome, 208050 (3)|SLC2A10, GLUT10, ATS|606145|20q13.12
Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)|TPM2, TMSB, AMCD1, DA1, DA2B, NEM4|190990|9p13.3
Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)|TNNI2, AMCD2B, DA2B, FSSV|191043|11p15.5
Arthrogryposis multiplex congenita, neurogenic (2)|AMCN, AMCN1|208100|5q35
Arthrogryposis, distal, type 1B, 614335 (3)|MYBPC1|160794|12q23.2
Arthrogryposis, distal, type 2A, 193700 (3)|MYH3|160720|17p13.1
Arthrogryposis, distal, type 2B, 601680 (3)|MYH3|160720|17p13.1
Arthrogryposis, distal, type 2B, 601680 (3)|TPM2, TMSB, AMCD1, DA1, DA2B, NEM4|190990|9p13.3
Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)|GLE1, GLE1L, LCCS, LCCS1|603371|9q34.11
Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)|VPS33B|608552|15q26.1
Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)|VIPAR, SPE39, C14orf133|613401|14q24.3
Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3)|WISP3, PPAC, PPD|603400|6q21
Arthyrgryposis, distal, type 2B, 601680 (3)|TNNT3, AMCD2B, DA2B, FSSV|600692|11p15.5
Arts syndrome, 301835 (3)|PRPS1, CMTX5, DFNX1, DFN2|311850|Xq22.3
Aspartate aminotransferase, serum level of, QTL1, 614419 (3)|GOT1, ASTQTL1|138180|10q24.2
Aspartylglucosaminuria, 208400 (3)|AGA|613228|4q34.3
Asphyxiating thoracic dystrophy 1 (2)|ATD1|208500|15q13
Asphyxiating thoracic dystrophy 2, 611263 (3)|IFT80, KIAA1374, WDR56, ATD2|611177|3q25.33
Asphyxiating thoracic dystrophy 3, 613091 (3)|DYNC2H1, DNCH2, DHC2, ATD3|603297|11q22.3
Asphyxiating thoracic dystrophy 4, 613819 (3)|TTC21B, THM1, NPHP12, ATD4|612014|2q24.3
Asphyxiating thoracic dystrophy 5, 614376 (3)|WDR19, ATD5, NPHP13, CED4|608151|4p14
Asthma and nasal polyps, 208550 (3)|TBX21, TBET|604895|17q21.32
Ataxia with isolated vitamin E deficiency, 277460 (3)|TTPA, TTP1, AVED|600415|8q12.3
Ataxia, cerebellar, Cayman type, 601238 (3)|ATCAY, CLAC, KIAA1872|608179|19p13.3
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)|APTX, AOA, AOA1|606350|9p21.1
Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)|FLVCR1, AXPC1, PCARP|609144|1q32.3
Ataxia, sensory, 1, autosomal dominant, 608984 (3)|RNF170, SNAX1|614649|8p11.21
Ataxia, spastic 2, autosomal recessive (2)|SPAX2|611302|17p13
Ataxia, spastic, 3, autosomal recessive (2)|SPAX3, ARSAL|611390|2q33-q34
Ataxia, spastic, 4, 613672 (3)|MTPAP, PAPD1, SPAX4|613669|10p11.23
Ataxia, spastic, 5, autosomal recessive, 614487 (3)|AFG3L2, SCA28, SPAX5|604581|18p11.21
Ataxia-ocular apraxia-2, 606002 (3)|SETX, SCAR1, AOA2, ALS4|608465|9q34.13
Ataxia-telangiectasia, 208900 (3)|ATM, ATA, AT1|607585|11q22.3
Ataxia-telangiectasia-like disorder, 604391 (3)|MRE11A, MRE11, ATLD|600814|11q21
Atelosteogenesis II, 256050 (3)|SLC26A2, DTD, DTDST, D5S1708, EDM4|606718|5q32
Atelosteogenesis, type I, 108720 (3)|FLNB, SCT, AOI, LRS1|603381|3p14.3
Atelosteogenesis, type III, 108721 (3)|FLNB, SCT, AOI, LRS1|603381|3p14.3
Athabaskan brainstem dysgenesis syndrome, 601536 (3)|HOXA1, HOX1F, BSAS|142955|7p15.2
Atopy, 147050 (3)|SPINK5, LEKTI|605010|5q32
Atransferrinemia, 209300 (3)|TF, TFQTL1|190000|3q22.1
Atrial fibrillation, familial, 1 (2)|ATFB1|608583|10q22-q24
Atrial fibrillation, familial, 10, 614022 (3)|SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2|600163|3p22.2
Atrial fibrillation, familial, 11, 614049 (3)|GJA5, CX40, ATFB11|121013|1q21.2
Atrial fibrillation, familial, 12, 614050 (3)|ABCC9, SUR2, CMD1O, ATFB12, CANTU|601439|12p12.1
Atrial fibrillation, familial, 2 (2)|ATFB2|608988|6q14-q16
Atrial fibrillation, familial, 3, 607554 (3)|KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2|607542|11p15.5-p15.4
Atrial fibrillation, familial, 4, 611493 (3)|KCNE2, MIRP1, LQT6, ATFB4|603796|21q22.11
Atrial fibrillation, familial, 6, 612201 (3)|NPPA, PND, ANP, ATFB6|108780|1p36.22
Atrial fibrillation, familial, 7, 612240 (3)|KCNA5, ATFB7|176267|12p13.32
Atrial fibrillation, familial, 8 (2)|ATFB8|613055|16q22
Atrial fibrillation, familial, 9, 613980 (3)|KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9|600681|17q24.3
Atrial septal defect 1 (2)|ASD1|108800|5p
Atrial septal defect 2, 607941 (3)|GATA4, ASD2, VSD1|600576|8p23.1
Atrial septal defect 3, 614089 (3)|MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3|160710|14q11.2
Atrial septal defect 4, 611363 (3)|TBX20, ASD4|606061|7p14.2
Atrial septal defect 5, 612794 (3)|ACTC1, CMD1R, CMH11, ASD5, LVNC4|102540|15q14
Atrial septal defect 6, 613087 (3)|TLL1, TLL, ASD6|606742|4q32.3
Atrial septal defect 7, with or without AV conduction defects, 108900 (3)|NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2|600584|5q35.1
Atrial septal defect 8, 614433 (3)|CITED2, MRG1, P35SRJ, VSD2, ASD8|602937|6q24.1
Atrial septal defect 9, 614475 (3)|GATA6, AVSD5, ASD9, AVSD5, PACHD|601656|18q11.2
Atrichia with papular lesions, 209500 (3)|HR, AU, MUHH1|602302|8p21.3
Atrioventricular block, second-degree (3)|NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2|600584|5q35.1
Atrioventricular septal defect 3, 600309 (3)|GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1|121014|6q22.31
Atrioventricular septal defect 4, 614430 (3)|GATA4, ASD2, VSD1|600576|8p23.1
Atrioventricular septal defect 5, 614474 (3)|GATA6, AVSD5, ASD9, AVSD5, PACHD|601656|18q11.2
Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)|CRELD1, AVSD2|607170|3p25.3
Atypical mycobacteriosis, familial, X-linked 2, 300645 (3)|CYBB, CGD, AMCBX2|300481|Xp11.4
Auditory neuropathy, autosomal dominant, 1, 609129 (3)|DIAPH3, DIA2, DRF3, AUNA1, NSDAN|614567|13q21.2
Auditory neuropathy, autosomal recessive, 1, 601071 (3)|OTOF, DFNB9, NSRD9, AUNB1|603681|2p23.3
Aural atresia, congenital (2)|CAA|607842|18q22.3-q23
Aural atresia, congenital, 607842 (3)|TSHZ1, TSH1, CAA|614427|18q22.3
Auriculocondylar syndrome 1, 602483 (3)|GNAI3, ARCND1|139370|1p13.3
Auriculocondylar syndrome 2, 614669 (3)|PLCB4, ARCND2|600810|20p12.3-p12.2
Autoimmune disease, syndromic multisystem, 613385 (3)|ITCH, AIP4, NAPP1|606409|20q11.22
Autoimmune lymphoproliferative syndrome type IV, 614470 (3)|NRAS, ALPS4, NS6|164790|1p13.2
Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)|TNFRSF6, APT1, FAS, CD95, ALPS1A|134637|10q23.31
Autoimmune lymphoproliferative syndrome, type IB, 601859 (3)|TNFSF6, APT1LG1, FASL, ALPS1B|134638|1q24.3
Autoimmune lymphoproliferative syndrome, type II, 603909 (3)|CASP10, MCH4, ALPS2|601762|2q33.1
Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)|AIRE, APECED, APS1|607358|21q22.3
Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)|PSMB8, LMP7, RING10, JMP, NKJO, ALDD|177046|6p21.32
Autonomic nervous system dysfunction (3)|DRD4|126452|11p15.5
Avascular necrosis of the femoral head, 608805 (3)|COL2A1|120140|12q13.11
Axenfeld-Rieger syndrome, type 1, 180500 (3)|PITX2, IDG2, RIEG1, RGS, IGDS2|601542|4q25
Axenfeld-Rieger syndrome, type 3, 602482 (3)|FOXC1, FKHL7, FREAC3, IRID1, RIEG3|601090|6p25.3
B-cell non-Hodgkin lymphoma, high-grade (3)|BCL7A, BCL7|601406|12q24.31
BCG and salmonella infection, disseminated, 209950 (1)|IL12B, NKSF2|161561|5q33.3
BCG infection, generalized familial, 209950 (3)|IFNGR1|107470|6q23.3
Baller-Gerold syndrome, 218600 (3)|RECQL4, RTS, RECQ4|603780|8q24.3
Bamforth-Lazarus syndrome, 241850 (3)|FOXE1, FKHL15, TITF2, TTF2|602617|9q22.33
Band-like calcification with simplified gyration and polymicrogyria, 251290 (3)|OCLN, BLCPMG|602876|5q13.2
Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)|PTEN, MMAC1, GLM2|601728|10q23.31
Baraitser-Winter syndrome 2, 243310 (3)|ACTB, BRWS1|102630|7p22.1
Baraitser-Winter syndrome 2, 614583 (3)|ACTG1, DFNA20, DFNA26, BRWS2|102560|17q25.3
Bardet-Biedl syndrome 1, 209900 (3)|BBS1|209901|11q13.2
Bardet-Biedl syndrome 10, 209900 (3)|BBS10, C12orf58, FLJ23560|610148|12q21.2
Bardet-Biedl syndrome 11, 209900 (3)|TRIM32, HT2A, LGMD2H, BBS11|602290|9q33.1
Bardet-Biedl syndrome 12, 209900 (3)|BBS12, FLJ35630, C4orf24|610683|4q27
Bardet-Biedl syndrome 13, 209900 (3)|MKS1, MKS, BBS13|609883|17q22
Bardet-Biedl syndrome 14, 209900 (3)|CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14|610142|12q21.32
Bardet-Biedl syndrome 15, 209900 (3)|C2orf86, BBS15|613580|2p15
Bardet-Biedl syndrome 2, 209900 (3)|BBS2|606151|16q12.2
Bardet-Biedl syndrome 3, 209900 (3)|ARL6, BBS3, RP55|608845|3q11.2
Bardet-Biedl syndrome 4, 209900 (3)|BBS4|600374|15q24.1
Bardet-Biedl syndrome 5, 209900 (3)|BBS5|603650|2q31.1
Bardet-Biedl syndrome 6, 209900 (3)|MKKS, HMCS, KMS, MKS, BBS6|604896|20p12.2
Bardet-Biedl syndrome 7, 209900 (3)|BBS7|607590|4q27
Bardet-Biedl syndrome 8, 209900 (3)|TTC8, BBS8, RP51|608132|14q31.3
Bardet-Biedl syndrome 9, 209900 (3)|PTHB1, BBS9|607968|7p14.3
Bare lymphocyte syndrome, type I, 604571 (3)|TAP1, ABCB2, TAP1, RING4, PSF1|170260|6p21.32
Bare lymphocyte syndrome, type I, 604571 (3)|TAPBP, TPSN|601962|6p21.32
Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)|TAP2, ABCB3, PSF2, RING11|170261|6p21.32
Bare lymphocyte syndrome, type II, complementation group A, 209920 (3)|MHC2TA, C2TA|600005|16p13.13
Bare lymphocyte syndrome, type II, complementation group C, 209920 (3)|RFX5|601863|1q21.3
Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)|RFXAP|601861|13q13.3
Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)|RFX5|601863|1q21.3
